Matrix Metalloproteinase‐9‐Responsive Surface Charge‐Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy. Issue 9 (10th March 2021)
- Record Type:
- Journal Article
- Title:
- Matrix Metalloproteinase‐9‐Responsive Surface Charge‐Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy. Issue 9 (10th March 2021)
- Main Title:
- Matrix Metalloproteinase‐9‐Responsive Surface Charge‐Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy
- Authors:
- Han, Qiu‐Ju
Lan, Xiao‐Tong
Wen, Ying
Zhang, Chuan‐Zeng
Cleary, Michael
Sayyed, Yasra
Huang, Guangdong
Tuo, Xiaoling
Yi, Long
Xi, Zhen
Li, Lu‐Yuan
Zhang, Qiang‐Zhe - Abstract:
- Abstract: Nanoparticles, that can be enriched in the tumor microenvironment and deliver the payloads into cancer cells, are desirable carriers for theranostic agents in cancer diagnosis and treatment. However, efficient targeted delivery and enhanced endocytosis for probes and drugs in theranostics are still major challenges. Here, a nanoparticle, which is capable of charge reversal from negative to positive in response to matrix metalloproteinase 9 (MMP9) in tumor microenvironment is reported. This nanoparticle is based on a novel charge reversible amphiphilic molecule consisting of hydrophobic oleic acid, MMP9‐cleavable peptide, and glutamate‐rich segment (named as OMPE). The OMPE‐modified cationic liposome forms an intelligent anionic nanohybrid (O‐NP) with enhanced endocytosis through surface charge reversal in response to MMP9 in vitro. Successfully, O‐NP nanohybrid performs preferential accumulation and enhances the endocytosis in MMP9‐expressing xenografted tumors in mouse models, which improve the sensitivity of diagnosis agents and the antitumor effects of drugs in vivo by overcoming their low solubility and/or nonspecific enrichment. These results indicate that O‐NP can be a promising delivery platform for cancer diagnosis and therapy. Abstract : Functional amphiphilic molecule (OMPE) consists of three motifs, hydrophobic oleic acid, MMP9‐responsive cleavable peptide connecting a glutamate‐rich segment. When encountered MMP9 overexpressed microenvironment, theAbstract: Nanoparticles, that can be enriched in the tumor microenvironment and deliver the payloads into cancer cells, are desirable carriers for theranostic agents in cancer diagnosis and treatment. However, efficient targeted delivery and enhanced endocytosis for probes and drugs in theranostics are still major challenges. Here, a nanoparticle, which is capable of charge reversal from negative to positive in response to matrix metalloproteinase 9 (MMP9) in tumor microenvironment is reported. This nanoparticle is based on a novel charge reversible amphiphilic molecule consisting of hydrophobic oleic acid, MMP9‐cleavable peptide, and glutamate‐rich segment (named as OMPE). The OMPE‐modified cationic liposome forms an intelligent anionic nanohybrid (O‐NP) with enhanced endocytosis through surface charge reversal in response to MMP9 in vitro. Successfully, O‐NP nanohybrid performs preferential accumulation and enhances the endocytosis in MMP9‐expressing xenografted tumors in mouse models, which improve the sensitivity of diagnosis agents and the antitumor effects of drugs in vivo by overcoming their low solubility and/or nonspecific enrichment. These results indicate that O‐NP can be a promising delivery platform for cancer diagnosis and therapy. Abstract : Functional amphiphilic molecule (OMPE) consists of three motifs, hydrophobic oleic acid, MMP9‐responsive cleavable peptide connecting a glutamate‐rich segment. When encountered MMP9 overexpressed microenvironment, the negative charge of the polyglutamates motif of the OMPE is eliminated, thus the surface charge of the anionic nanocarrier (OMPE‐modified cationic nanoparticles, O‐NP) reverses to cationic resulting in facilitated endocytosis and targeted tumor theranostics. … (more)
- Is Part Of:
- Advanced healthcare materials. Volume 10:Issue 9(2021)
- Journal:
- Advanced healthcare materials
- Issue:
- Volume 10:Issue 9(2021)
- Issue Display:
- Volume 10, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 10
- Issue:
- 9
- Issue Sort Value:
- 2021-0010-0009-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-03-10
- Subjects:
- charge reversal -- cleavable peptides -- delivery platforms -- liposomes -- MMP9‐responsive peptides
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2192-2659 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/adhm.202002143 ↗
- Languages:
- English
- ISSNs:
- 2192-2640
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0696.854650
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16896.xml